{"id":417570,"date":"2021-01-20T06:41:13","date_gmt":"2021-01-20T11:41:13","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=417570"},"modified":"2021-01-20T06:41:13","modified_gmt":"2021-01-20T11:41:13","slug":"exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\/","title":{"rendered":"EXACT Therapeutics Announces Innovative Probe Development Collaboration With GE Healthcare"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n OSLO, Norway<\/span> and LONDON<\/span>, Jan. 20, 2021<\/span> \/PRNewswire\/ — EXACT\u00a0THERAPEUTICS AS (“EXACT-Tx” or the “Company”), a clinical stage precision medicine company today announced a collaboration with GE Healthcare to develop an innovative ultrasound probe to be used in forthcoming studies using Acoustic Cluster Therapy (ACT\u00ae) across multiple disease conditions. <\/p>\n

“We are delighted to collaborate with GE Healthcare, a leader in the field of diagnostic imaging and ultrasound. We look forward to working closely with GE Healthcare in developing an innovative ultrasound probe with the goal of enabling effective deployment of the ACT\u00ae therapeutic amplification platform across indications for our forthcoming phase II clinical development program”, said Dr Rafiq Hasan<\/span>, CEO of EXACT Therapeutics AS. <\/p>\n

ACT\u00ae is a proprietary formulation consisting of microbubbles and microdroplets that are activated through the application of ultrasound with the consequent increase in targeted delivery of a co-administered therapeutic agent.\u00a0 ACT\u00ae is supported by a strong and broad preclinical package demonstrating therapeutic enhancement in multiple oncology models (pancreatic, breast, colon, prostate) as well as controlled blood-brain barrier opening. Currently ACT\u00ae is being evaluated in the international ACTIVATE Phase I clinical trial in patients with metastatic colorectal and pancreatic cancer at the Royal Marsden Hospital in London<\/span>. <\/p>\n

\n About EXACT<\/b>\n <\/p>\n

EXACT-Tx is a clinical stage Norwegian biotech company developing a technology platform for targeted therapeutic enhancement \u2013 Acoustic Cluster Therapy (ACT\u00ae). ACT\u00ae sonoporation is a unique approach to ultrasound-mediated, targeted drug enhancement \u2013 with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. www.exact-tx.com<\/a><\/u><\/p>\n

\n For more information contact:<\/b>\n <\/p>\n

Dr Rafiq Hasan<\/span>
CEO EXACT\u00a0Therapeutics
Rafiq@exact-tx.com<\/a><\/p>\n

\n Richard Hayhurst<\/span>\/Janet Joy<\/span>
Tel +44 7711 821527
richard@rhapr.eu<\/a><\/u><\/p>\n

\u00a0<\/p>\n

\n \"Cision\" View original content:http:\/\/www.prnewswire.com\/news-releases\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare-301211639.html<\/a><\/p>\n

SOURCE Exact Therapeutics<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire OSLO, Norway and LONDON, Jan. 20, 2021 \/PRNewswire\/ — EXACT\u00a0THERAPEUTICS AS (“EXACT-Tx” or the “Company”), a clinical stage precision medicine company today announced a collaboration with GE Healthcare to develop an innovative ultrasound probe to be used in forthcoming studies using Acoustic Cluster Therapy (ACT\u00ae) across multiple disease conditions. “We are delighted to collaborate with GE Healthcare, a leader in the field of diagnostic imaging and ultrasound. We look forward to working closely with GE Healthcare in developing an innovative ultrasound probe with the goal of enabling effective deployment of the ACT\u00ae therapeutic amplification platform across indications for our forthcoming phase II clinical development program”, said Dr Rafiq Hasan, CEO of EXACT Therapeutics AS. ACT\u00ae is a proprietary … <\/p>\n

Continue reading “EXACT Therapeutics Announces Innovative Probe Development Collaboration With GE Healthcare”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-417570","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nEXACT Therapeutics Announces Innovative Probe Development Collaboration With GE Healthcare - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EXACT Therapeutics Announces Innovative Probe Development Collaboration With GE Healthcare - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire OSLO, Norway and LONDON, Jan. 20, 2021 \/PRNewswire\/ — EXACT\u00a0THERAPEUTICS AS (“EXACT-Tx” or the “Company”), a clinical stage precision medicine company today announced a collaboration with GE Healthcare to develop an innovative ultrasound probe to be used in forthcoming studies using Acoustic Cluster Therapy (ACT\u00ae) across multiple disease conditions. “We are delighted to collaborate with GE Healthcare, a leader in the field of diagnostic imaging and ultrasound. We look forward to working closely with GE Healthcare in developing an innovative ultrasound probe with the goal of enabling effective deployment of the ACT\u00ae therapeutic amplification platform across indications for our forthcoming phase II clinical development program”, said Dr Rafiq Hasan, CEO of EXACT Therapeutics AS. ACT\u00ae is a proprietary … Continue reading "EXACT Therapeutics Announces Innovative Probe Development Collaboration With GE Healthcare"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-20T11:41:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN53930&sd=2021-01-20\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"EXACT Therapeutics Announces Innovative Probe Development Collaboration With GE Healthcare\",\"datePublished\":\"2021-01-20T11:41:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\\\/\"},\"wordCount\":312,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LN53930&sd=2021-01-20\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\\\/\",\"name\":\"EXACT Therapeutics Announces Innovative Probe Development Collaboration With GE Healthcare - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LN53930&sd=2021-01-20\",\"datePublished\":\"2021-01-20T11:41:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LN53930&sd=2021-01-20\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LN53930&sd=2021-01-20\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EXACT Therapeutics Announces Innovative Probe Development Collaboration With GE Healthcare\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EXACT Therapeutics Announces Innovative Probe Development Collaboration With GE Healthcare - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\/","og_locale":"en_US","og_type":"article","og_title":"EXACT Therapeutics Announces Innovative Probe Development Collaboration With GE Healthcare - Market Newsdesk","og_description":"PR Newswire OSLO, Norway and LONDON, Jan. 20, 2021 \/PRNewswire\/ — EXACT\u00a0THERAPEUTICS AS (“EXACT-Tx” or the “Company”), a clinical stage precision medicine company today announced a collaboration with GE Healthcare to develop an innovative ultrasound probe to be used in forthcoming studies using Acoustic Cluster Therapy (ACT\u00ae) across multiple disease conditions. “We are delighted to collaborate with GE Healthcare, a leader in the field of diagnostic imaging and ultrasound. We look forward to working closely with GE Healthcare in developing an innovative ultrasound probe with the goal of enabling effective deployment of the ACT\u00ae therapeutic amplification platform across indications for our forthcoming phase II clinical development program”, said Dr Rafiq Hasan, CEO of EXACT Therapeutics AS. ACT\u00ae is a proprietary … Continue reading \"EXACT Therapeutics Announces Innovative Probe Development Collaboration With GE Healthcare\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-20T11:41:13+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN53930&sd=2021-01-20","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"EXACT Therapeutics Announces Innovative Probe Development Collaboration With GE Healthcare","datePublished":"2021-01-20T11:41:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\/"},"wordCount":312,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN53930&sd=2021-01-20","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\/","name":"EXACT Therapeutics Announces Innovative Probe Development Collaboration With GE Healthcare - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN53930&sd=2021-01-20","datePublished":"2021-01-20T11:41:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN53930&sd=2021-01-20","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN53930&sd=2021-01-20"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"EXACT Therapeutics Announces Innovative Probe Development Collaboration With GE Healthcare"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/417570","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=417570"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/417570\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=417570"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=417570"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=417570"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}